Polymorphs and hydrates of acyclovir

Journal of Pharmaceutical Sciences

Volumn 100, Issue 3, 2011, Pages 949-963

  Lutker, Katie M ^a   Quiñones, Rosalynn ^a   Xu, Jiadi ^a   Ramamoorthy, Ayyalusamy ^a   Matzger, Adam J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Calorimetry (DSC); Crystal structure; FTIR spectroscopy; Polymorphism; hydrates; Raman spectroscopy; Solid state NMR spectroscopy; X ray diffractometry

Indexed keywords

ACICLOVIR; ACICLOVIR HYDRATE; ANHYDROUS ACICLOVIR; UNCLASSIFIED DRUG;

ARTICLE; ATMOSPHERE; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; HIGH TEMPERATURE; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; X RAY DIFFRACTION;

EID: 79251581589     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22336     Document Type: Article

References (20)

1. Brittain HG. 1999. Polymorphism in pharmaceutical solids. New York: Marcel Dekker.
2. Yu L, Reutzel-Edens SM, Mitchell CA. 2000. Crystallization and polymorphism of conformationally flexible molecules: Problems, patterns, and strategies. Org Process Res Dev 4(5):396-402
3. Lang MD, Grzesiak AL, Matzger AJ. 2002. The use of polymer heteronuclei for crystalline polymorph selection. J Am Chem Soc 124(50):14834-14835.
4. Price CP, Grzesiak AL, Matzger AJ. 2005. Crystalline polymorph selection and discovery with polymer heteronuclei. J Am Chem Soc 127(15):5512-5517.
5. Birnbaum GI, Cygler M, Kusmierek JT, Shugar D. 1981. Structure and conformation of the potent anti-herpes agent 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Biochem Biophys Res Commun 103(3):968-974.
6. Birnbaum GI, Cygler M, Shugar D. 1984. Conformational features of acyclonucleosides-structure of acyclovir, an antiherpes agent. Can J Chem 62(12):2646-2652.
7. Kristl A, Srcic S, Vrecer F, Sustar B, Vojnovic D. 1996. Polymorphism and pseudopolymorphism: Influencing the dissolution properties of the guanine derivative acyclovir. Int J Pharm 139(1-2):231-235.
8. Sohn YT, Kim SH. 2008. Polymorphism and pseudopolymorphism of acyclovir. Arch of Pharm Res 31(2):231-234.
9. Shefter E, Higuchi T. 1963. Dissolution Behavior of Crystalline Solvated and nonsolvated forms of some pharmaceuticals. J Pharm Sci 52:781-791.
10. Metz G, Wu X, Smith SO. 1994. Ramped-amplitude cross polarization in magic-angle-spinning NMR. J Magn Reson A 110(2):219-227.
11. Bennett AE, Rienstra CM, Auger M, Lakshmi KV, Griffin RG. 1995. Heteronuclear decoupling in rotating solids. J Chem Phys 103(16):6951-6958.
12. Birn J, Poon A, Mao Y, Ramamoorthy A. 2004. Ab initio study of 13Cα chemical shift anisotropy tensors in peptides. J Am Chem Soc 126(27):8529-8534.
13. Brender JR, Taylor DM, Ramamoorthy A. 2001. Orientation of amide-nitrogen-15 chemical shift tensors in peptides: A quantum chemical study. J Am Chem Soc 123(5):914-922.
14. McGuire GE, Weiss PS, Kushmerick JG, Johnson JA, Simko SJ, Nemanich RJ. 1997. Surface characterization. Anal Chem 69:231R-250R.
15. Threlfall TL. 1995. Analysis of organic polymorphs: A review. Analyst 120:2435-2459.
16. Harris RK. 2006. NMR studies of organic polymorphs & solvates. Analyst 131(3):351-373.
17. Harris RK. 2007. Applications of solid-state NMR to pharmaceutical polymorphism and related matters. J Pharm Pharmacol 59(2):225-239.
18. Gobetto R, Nervi C, Valfre E, Chierotti MR, Braga D, Maini L, Grepioni F, Harris RK, Ghi PY. 2005. H-1 MAS, N-15 CPMAS, and DFT investigation of hydrogen-bonded supramolecular adducts between the diamine 1, 4-diazabicyclo-[2.2.2]octane and dicarboxylic acids of variable chain length. Chem Mater 17(6):1457-1466.
19. Rubin-Preminger JM, Bernstein J, Harris RK, Evans IR, Ghi PY. 2004. Variable temperature studies of a polymorphic system comprising two pairs of enantiotropically related forms: [S, S]-ethambutol dihydrochloride. Cryst Growth Des 4(3):431-439.
20. Stephenson GA, Stowell JG, Toma PH, Dorman DE, Greene JR, Byrn SR. 1994. Solid-state analysis of polymorphic, isomorphic, and solvated forms of dirithromycin. J Am Chem Soc 116(13):5766-5773.